Rhythm Pharmaceuticals, Inc. (RYTM)
113.56
-4.06
(-3.45%)
USD |
NASDAQ |
Dec 12, 14:04
Rhythm Pharmaceuticals Research and Development Expense (Quarterly): 45.92M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 1.334B |
| Terns Pharmaceuticals, Inc. | 19.92M |
| Altimmune, Inc. | 14.93M |
| Viking Therapeutics, Inc. | 89.95M |
| Cidara Therapeutics, Inc. | 35.53M |